{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:06:37Z","timestamp":1791219997349,"version":"4.1.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Children's National Health System"},{"name":"Myelin Disorders Bioregistry Project"},{"name":"Fonds de Recherche du Qu\u00e9bec en Sant\u00e9"},{"name":"Montreal Children's Hospital"},{"name":"McGill University Health Center Research Institutes"},{"name":"R\u00e9seau de M\u00e9decine G\u00e9n\u00e9tique Appliqu\u00e9e"},{"name":"Fondation sur les Leucodystrophies"},{"name":"Fondation du Grand D\u00e9fi Pierre Lavoie"},{"name":"Fondation Les Amis D'\u00c9lliot"},{"name":"Fondation D\u00e9sir\u00e9e le Papillon"},{"DOI":"10.13039\/100008762","name":"Genome Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008762","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002879","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002879","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.ymgme.2015.01.014","type":"journal-article","created":{"date-parts":[[2015,2,7]],"date-time":"2015-02-07T16:55:59Z","timestamp":1423328159000},"page":"527-536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Disease specific therapies in leukodystrophies and leukoencephalopathies"],"prefix":"10.1016","volume":"114","author":[{"given":"Guy","family":"Helman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Van Haren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua L.","family":"Bonkowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Pizzino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Braverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Suhr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc C.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ali Fatemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjo S.","family":"van der Knaap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Back","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Damiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asako","family":"Takanohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Petryniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rowitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albee","family":"Messing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Wrabetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Schiffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Eichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L.","family":"Escolar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Vanderver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2015.01.014_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2014.12.434","article-title":"A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephalopathies","author":"Parikh","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2015.01.006","article-title":"Case definition and classification of leukodystrophies and leukoencephalopathies","author":"Vanderver","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0265","series-title":"Consensus Statement on Preventive and Symptomatic Care of Leukodystrophy Patients","author":"Van Haren","year":"2015"},{"key":"10.1016\/j.ymgme.2015.01.014_bb0270","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1750-1172-7-51","article-title":"X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management","volume":"7","author":"Engelen","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0275","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1182\/blood-2003-10-3402","article-title":"Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999","volume":"104","author":"Peters","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2015.01.014_bb0280","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0140-6736(00)02629-5","article-title":"Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy","volume":"356","author":"Shapiro","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2015.01.014_bb0285","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood-2011-01-329235","article-title":"Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report","volume":"118","author":"Miller","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2015.01.014_bb0290","doi-asserted-by":"crossref","first-page":"e50430","DOI":"10.1371\/journal.pone.0050430","article-title":"Cerebrospinal fluid matrix metalloproteinases are elevated in cerebral adrenoleukodystrophy and correlate with MRI severity and neurologic dysfunction","volume":"7","author":"Thibert","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymgme.2015.01.014_bb0295","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2015.01.014_bb0300","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ymgme.2013.10.019","article-title":"Newborn screening for X-linked adrenoleukodystrophy: further evidence high throughput screening is feasible","volume":"111","author":"Theda","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0305","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archneur.62.7.1073","article-title":"Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil","volume":"62","author":"Moser","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0310","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1194\/jlr.M044586","article-title":"Lorenzo's oil inhibits ELOVL1 and lowers the level of sphingomyelin with a saturated very long-chain fatty acid","volume":"55","author":"Sassa","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0315","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1586\/14737175.8.9.1367","article-title":"Therapy of X-linked adrenoleukodystrophy","volume":"8","author":"Semmler","year":"2008","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0320","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1517\/13543770903567069","article-title":"Thyromimetics: a review of recent reports and patents (2004\u20132009)","volume":"20","author":"Hirano","year":"2010","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0325","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1093\/hmg\/ddt645","article-title":"X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes","volume":"23","author":"Weber","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0330","doi-asserted-by":"crossref","first-page":"1233158","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2015.01.014_bb0335","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ymgme.2010.06.017","article-title":"Adult Polyglucosan Body Disease (APBD): anaplerotic diet therapy (Triheptanoin) and demonstration of defective methylation pathways","volume":"101","author":"Roe","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0340","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/ng1845","article-title":"Mutations in the gene encoding the 3\u2032-5\u2032 DNA exonuclease TREX1 cause Aicardi\u2013Goutieres syndrome at the AGS1 locus","volume":"38","author":"Crow","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0345","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/ng1842","article-title":"Mutations in genes encoding ribonuclease H2 subunits cause Aicardi\u2013Goutieres syndrome and mimic congenital viral brain infection","volume":"38","author":"Crow","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0350","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ng.373","article-title":"Mutations involved in Aicardi\u2013Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response","volume":"41","author":"Rice","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0355","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng.2414","article-title":"Mutations in ADAR1 cause Aicardi\u2013Goutieres syndrome associated with a type I interferon signature","volume":"44","author":"Rice","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0360","series-title":"Characterization of Human Disease Phenotypes Associated With Mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR and IFIH1","author":"Crow","year":"2015"},{"key":"10.1016\/j.ymgme.2015.01.014_bb0365","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1399-0004.2011.01825.x","article-title":"Aicardi\u2013Goutieres syndrome: from patients to genes and beyond","volume":"81","author":"Chahwan","year":"2012","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0370","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.coi.2012.09.007","article-title":"Endogenous retroelements and autoimmune disease","volume":"24","author":"Stetson","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0375","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cell.2008.06.032","article-title":"Trex1 prevents cell-intrinsic initiation of autoimmunity","volume":"134","author":"Stetson","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.ymgme.2015.01.014_bb0380","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.celrep.2013.08.019","article-title":"Modulation of LINE-1 and Alu\/SVA retrotransposition by Aicardi\u2013Goutieres syndrome-related SAMHD1","volume":"4","author":"Zhao","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0385","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1742-4690-8-91","article-title":"An autoimmune disease prevented by anti-retroviral drugs","volume":"8","author":"Beck-Engeser","year":"2011","journal-title":"Retrovirology"},{"key":"10.1016\/j.ymgme.2015.01.014_bb0390","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1212\/WNL.0b013e3182309f72","article-title":"GFAP mutations, age at onset, and clinical subtypes in Alexander disease","volume":"77","author":"Prust","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2015.01.014_bb0395","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/ajmg.1320290234","article-title":"Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease","volume":"29","author":"Matalon","year":"1988","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0400","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/1531-8249(200007)48:1<27::AID-ANA6>3.0.CO;2-6","article-title":"Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease","volume":"48","author":"Leone","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0405","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003454","article-title":"Long-term follow-up after gene therapy for canavan disease","volume":"4","author":"Leone","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0005","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJM198412273112601","article-title":"Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid","volume":"311","author":"Berginer","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0010","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/jnnp.55.1.52","article-title":"Electrophysiological studies in cerebrotendinous xanthomatosis","volume":"55","author":"Tokimura","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2015.01.014_bb0015","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1468-1331.2011.03439.x","article-title":"Cerebrotendinous xanthomatosis in Spain: clinical, prognostic, and genetic survey","volume":"18","author":"Pilo-de-la-Fuente","year":"2011","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"10.1016\/j.ymgme.2015.01.014_bb0020","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1212\/WNL.0000000000001157","article-title":"DARS-associated leukoencephalopathy can mimic a steroid-responsive neuroinflammatory disorder","volume":"84","author":"Wolf","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2015.01.014_bb0025","series-title":"Aminoacyl\u2013tRNA Synthetases in Biology and Medicine","first-page":"167","article-title":"Non-catalytic regulation of gene expression by aminoacyl\u2013tRNA synthetases","author":"Yao","year":"2014"},{"key":"10.1016\/j.ymgme.2015.01.014_bb0030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00281-004-0166-2","article-title":"Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases","volume":"26","author":"Krivit","year":"2004","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0035","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1056\/NEJMoa042604","article-title":"Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease","volume":"352","author":"Escolar","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00019052-199904000-00007","volume":"12","author":"Krivit","year":"1999","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0045","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbmt.2013.01.010","article-title":"Neurodevelopmental outcomes of umbilical cord blood transplantation in metachromatic leukodystrophy","volume":"19","author":"Martin","year":"2013","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0050","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/B978-0-444-59565-2.00029-0","article-title":"Lysosomal leukodystrophies: Krabbe disease and metachromatic leukodystrophy","volume":"113","author":"Kohlschutter","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0055","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/GIM.0b013e3181a16e04","article-title":"The long-term outcomes of presymptomatic infants transplanted for Krabbe disease: report of the workshop held on July 11 and 12, 2008, Holiday Valley, New York","volume":"11","author":"Duffner","year":"2009","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0060","doi-asserted-by":"crossref","first-page":"e879","DOI":"10.1542\/peds.2006-0747","article-title":"A staging system for infantile Krabbe disease to predict outcome after unrelated umbilical cord blood transplantation","volume":"118","author":"Escolar","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2015.01.014_bb0065","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3174\/ajnr.A1476","article-title":"Diffusion tensor imaging detects abnormalities in the corticospinal tracts of neonates with infantile Krabbe disease AJNR","volume":"30","author":"Escolar","year":"2009","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0070","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/(SICI)1098-1004(1997)10:4<268::AID-HUMU2>3.0.CO;2-D","article-title":"Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications","volume":"10","author":"Wenger","year":"1997","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0075","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1203\/PDR.0b013e3181baa083","article-title":"Endoplasmic reticulum stress, inflammation, and perinatal brain damage","volume":"66","author":"Bueter","year":"2009","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0080","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1002\/jnr.22066","article-title":"Myelin under stress","volume":"87","author":"D'Antonio","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0085","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1096\/fj.07-099671","article-title":"Molecular and cellular aspects of protein misfolding and disease","volume":"22","author":"Herczenik","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0090","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000112332","article-title":"Partial enzyme deficiencies: residual activities and the development of neurological disorders","volume":"6","author":"Conzelmann","year":"1983","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0095","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1742-4658.2006.05181.x","article-title":"Protein-misfolding diseases and chaperone-based therapeutic approaches","volume":"273","author":"Chaudhuri","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0100","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1021\/jm301557k","article-title":"Pharmacological chaperones as therapeutics for lysosomal storage diseases","volume":"56","author":"Boyd","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0105","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/adt.2011.0370","article-title":"Identification and characterization of pharmacological chaperones to correct enzyme deficiencies in lysosomal storage disorders","volume":"9","author":"Valenzano","year":"2011","journal-title":"Assay Drug Dev. Technol."},{"issue":"4","key":"10.1016\/j.ymgme.2015.01.014_bb0110","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ymgme.2014.05.009","article-title":"Pharmacological chaperones increase residual beta-galactocerebrosidase activity in fibroblasts from Krabbe patients","volume":"112","author":"Berardi","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ab.2012.10.034","article-title":"A high-throughput screening assay using Krabbe disease patient cells","volume":"434","author":"Ribbens","year":"2013","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0120","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00247-012-2523-y","article-title":"Gallbladder polyposis in metachromatic leukodystrophy","volume":"43","author":"Agarwal","year":"2013","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0125","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/sj.bmt.1705581","article-title":"Early marrow transplantation in a pre-symptomatic neonate with late infantile metachromatic leukodystrophy does not halt disease progression","volume":"39","author":"Bredius","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0130","first-page":"1003","article-title":"Clinical outcome in four children with metachromatic leukodystrophy treated by bone marrow transplantation","volume":"17","author":"Malm","year":"1996","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0135","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMe058071","article-title":"Early use of drastic therapy","volume":"352","author":"Weinberg","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0140","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/BF00710052","article-title":"The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome","volume":"18","author":"Krivit","year":"1995","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0145","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10545-007-0540-z","article-title":"Enzyme, cell and gene-based therapies for metachromatic leukodystrophy","volume":"30","author":"Sevin","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0150","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ana.21522","article-title":"Umbilical cord blood transplantation for juvenile metachromatic leukodystrophy","volume":"64","author":"Pierson","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0155","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ymgme.2010.10.002","article-title":"Unrelated umbilical cord blood transplant for juvenile metachromatic leukodystrophy: a 5-year follow-up in three affected siblings","volume":"102","author":"Cable","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0160","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/jamaneurol.2013.629","article-title":"Improvement of white matter changes on neuroimaging modalities after stem cell transplant in metachromatic leukodystrophy","volume":"70","author":"van Egmond","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0165","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1093\/hmg\/dds086","article-title":"Efficacy of enzyme replacement therapy in an aggravated mouse model of metachromatic leukodystrophy declines with age","volume":"21","author":"Matthes","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0170","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/glia.22591","article-title":"Insertion of proteolipid protein into oligodendrocyte mitochondria regulates extracellular pH and adenosine triphosphate","volume":"62","author":"Appikatla","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.ymgme.2015.01.014_bb0175","doi-asserted-by":"crossref","first-page":"155ra136","DOI":"10.1126\/scitranslmed.3004371","article-title":"Human neural stem cells induce functional myelination in mice with severe dysmyelination","volume":"4","author":"Uchida","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0180","series-title":"Paper Presented at the American College of Medical Genetics","author":"Trepanier","year":"2010"},{"key":"10.1016\/j.ymgme.2015.01.014_bb0185","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004373","article-title":"Neural stem cell engraftment and myelination in the human brain","volume":"4","author":"Gupta","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0190","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ddrr.1113","article-title":"Peroxisome biogenesis disorders: biological, clinical and pathophysiological perspectives","volume":"17","author":"Braverman","year":"2013","journal-title":"Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0195","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1203\/00006450-200206000-00008","article-title":"PEX1 mutations in complementation group 1 of Zellweger spectrum patients correlate with severity of disease","volume":"51","author":"Preuss","year":"2002","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0200","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/(SICI)1098-1004(1999)14:1<45::AID-HUMU6>3.0.CO;2-J","article-title":"Identification of a common PEX1 mutation in Zellweger syndrome","volume":"14","author":"Collins","year":"1999","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0205","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1086\/321265","article-title":"Disorders of peroxisome biogenesis due to mutations in PEX1: phenotypes and PEX1 protein levels","volume":"69","author":"Walter","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0210","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1073\/pnas.0914960107","article-title":"Recovery of PEX1-Gly843Asp peroxisome dysfunction by small-molecule compounds","volume":"107","author":"Zhang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0215","series-title":"GeneReviews","article-title":"Pol III-Related Leukodystrophies","author":"Bernard","year":"1993"},{"key":"10.1016\/j.ymgme.2015.01.014_bb0220","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1474-4422(06)70440-9","article-title":"Vanishing white matter disease","volume":"5","author":"van der Knaap","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0225","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jns.2009.11.005","article-title":"Head trauma can initiate the onset of adreno-leukodystrophy","volume":"290","author":"Raymond","year":"2010","journal-title":"J. Neurol. Sci."},{"issue":"6","key":"10.1016\/j.ymgme.2015.01.014_bb0230","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.mito.2013.09.003","article-title":"G. for the Mitochondrial Medicine Society Clinical Directors Working, G. Clinical Director's Work, Practice patterns of mitochondrial disease physicians in North America. Part 2: treatment, care and management","volume":"13","author":"Parikh","year":"2013","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ymgme.2015.01.014_bb0235","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1754-4505.2012.00248.x","article-title":"Medical\u2013dental findings and management of a child with infantile Refsum disease: a case report","volume":"32","author":"Acharya","year":"2012","journal-title":"Spec. Care Dentist."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0240","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1212\/WNL.0b013e3181eee46b","article-title":"The burden of inherited leukodystrophies in children","volume":"75","author":"Bonkowsky","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2015.01.014_bb0245","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/(SICI)1096-8628(19970905)71:4<475::AID-AJMG20>3.0.CO;2-C","article-title":"Leukodystrophy incidence in Germany","volume":"71","author":"Heim","year":"1997","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2015.01.014_bb0250","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.spen.2012.10.001","article-title":"Relative incidence of inherited white matter disorders in childhood to acquired pediatric demyelinating disorders","volume":"19","author":"Vanderver","year":"2012","journal-title":"Semin. Pediatr. Neurol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719215000360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719215000360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T23:00:56Z","timestamp":1589497256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719215000360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":81,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1096719215000360"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2015.01.014","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease specific therapies in leukodystrophies and leukoencephalopathies","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2015.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}